Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (8447)	11/5/2001 11:41:35 PM
From: RockyBalboa	Respond to of 10293

HEB....worse: What a stinky PR: Monday November 5, 11:07 am Eastern Time Press Release SOURCE: Hemispherx Biopharma Hemispherx Biopharma Announces Extension of Warrant Expiration to November 21, 2001 Due to Communications Disruptions Caused by the Events of September 11, 2001 Robust Conversions Already Exceed Several Million Dollars PHILADELPHIA--(BUSINESS WIRE)--Nov. 5, 2001-- Hemispherx Biopharma, Inc. (AMEX: HEB - news), a leading biopharmaceutical company specializing in the development of drug candidates to enhance the immune defense system in the human body, announced today that due to difficulties being experienced by the global investment community, including disruptions in telecommunications, mail and information transfer, it will extend the warrant expiration date to 5 PM, Eastern Standard Time, November 21, 2001. During this brief extension of the redemption period, the warrant will no longer be publicly traded on the American Stock Exchange. The Company further announced that holders might continue to exercise conversion either through their brokerage firm or directly with the Company. To work directly with the Company, holders should provide check (or money order), by Certified Mail, Return Receipt Requested, in an amount equal to $4.00 per share, payable to Hemispherx Biopharma, Inc., 1617 JFK Boulevard, Suite 660, Philadelphia, PA 19103. Dr. William Carter, Hemispherx chairman, president, and chief executive officer, commenting on the action, said, ``Many warrant holders-desiring to convert their warrants into HEB shares- have reported to us unusual delays and /or inadvertent misinformation when processing their funds and related warrant documents through their brokerage firms. In spite of this, and the fact that the warrant ceased trading with the stock literally at the warrant conversion price, we have received substantial conversion proceeds, and the total continues to increase. We believe this reflects a strong belief in the future value of our stock, and we therefore wish to afford our investors a brief additional period of time to overcome the obstacles they may have faced in completing the conversion process.'' biz.yahoo.com